Semi-Annual Statement Of Income

JCR Pharmaceuticals Co.,Ltd. - Filing #7295903

Concept 2024-04-01 to
2024-09-30
2023-04-01 to
2023-09-30
Semi-annual statement of income
Statement of income
Net sales
16,657,000,000 JPY
24,272,000,000 JPY
Cost of sales
4,330,000,000 JPY
5,881,000,000 JPY
Ordinary profit (loss)
-1,621,000,000 JPY
7,126,000,000 JPY
Gross profit (loss)
12,326,000,000 JPY
18,391,000,000 JPY
Extraordinary income
1,065,000,000 JPY
JPY
Selling, general and administrative expenses
13,066,000,000 JPY
11,493,000,000 JPY
Extraordinary losses
0 JPY
5,000,000 JPY
Selling, general and administrative expenses
Profit (loss) before income taxes
-556,000,000 JPY
7,120,000,000 JPY
Operating profit (loss)
-739,000,000 JPY
6,898,000,000 JPY
Income taxes - current
24,000,000 JPY
2,387,000,000 JPY
Non-operating income
134,000,000 JPY
796,000,000 JPY
Income taxes - deferred
100,000,000 JPY
-527,000,000 JPY
Non-operating income
Interest income
68,000,000 JPY
41,000,000 JPY
Dividend income
17,000,000 JPY
13,000,000 JPY
Income taxes
124,000,000 JPY
1,860,000,000 JPY
Non-operating expenses
1,016,000,000 JPY
568,000,000 JPY
Profit (loss)
-680,000,000 JPY
5,260,000,000 JPY
Non-operating expenses
Interest expenses
63,000,000 JPY
40,000,000 JPY
Extraordinary income
Extraordinary losses

Talk to a Data Expert

Have a question? We'll get back to you promptly.